13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001172661-25-001157
Total Value
$212.2M
Positions
26
Other Managers
2
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IONIS PHARMACEUTICALS INC | IONS | 505,007 | $17.7M | 8.32% |
| 2 | CYTOKINETICS INC | CYTK | 360,000 | $16.9M | 7.98% |
| 3 | KALVISTA PHARMACEUTICALS INC | KALV | 1,787,003 | $15.1M | 7.13% |
| 4 | VIRIDIAN THERAPEUTICS INC | VRDN | 750,000 | $14.4M | 6.78% |
| 5 | PLIANT THERAPEUTICS INC | PLRX | 1,055,000 | $13.9M | 6.55% |
| 6 | ABIVAX SA | AAVXF | 1,648,523 | $12.1M | 5.69% |
| 7 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 860,000 | $11.0M | 5.18% |
| 8 | NEUROGENE INC | NGNE | 442,761 | $10.1M | 4.77% |
| 9 | EVOLUS INC | EOLS | 895,524 | $9.9M | 4.66% |
| 10 | XENON PHARMACEUTICALS INC | XENE | 245,272 | $9.6M | 4.53% |
| 11 | UNICYCIVE THERAPEUTICS INC | UNCY | 10,980,000 | $8.7M | 4.11% |
| 12 | ZURA BIO LTD | ZURA | 3,170,194 | $7.9M | 3.73% |
| 13 | AUTOLUS THERAPEUTICS PLC | AUTL | 3,009,392 | $7.1M | 3.33% |
| 14 | JASPER THERAPEUTICS INC | JSPRW | 322,380 | $6.9M | 3.25% |
| 15 | MERUS N V | N5749R100 | 158,092 | $6.6M | 3.13% |
| 16 | DIANTHUS THERAPEUTICS INC | DNTH | 275,000 | $6.0M | 2.83% |
| 17 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.3M | 2.47% |
| 18 | UPSTREAM BIO INC | UPB | 300,000 | $4.9M | 2.32% |
| 19 | CONTEXT THERAPEUTICS INC | CNTX | 4,683,711 | $4.9M | 2.32% |
| 20 | VOYAGER THERAPEUTICS INC | VYGR | 826,751 | $4.7M | 2.21% |
| 21 | ORUKA THERAPEUTICS INC | ORKA | 228,803 | $4.4M | 2.09% |
| 22 | MEREO BIOPHARMA GROUP PLC | MREO | 1,150,000 | $4.0M | 1.90% |
| 23 | REZOLUTE INC | RZLT | 621,894 | $3.0M | 1.44% |
| 24 | PROMIS NEUROSCIENCES INC | PMN | 2,645,128 | $2.5M | 1.18% |
| 25 | OPTINOSE INC | 68404V209 | 370,269 | $2.5M | 1.17% |
| 26 | UROGEN PHARMA LTD | URGN | 187,843 | $2.0M | 0.94% |